Retatrutide

Triple GIP, GLP-1 and glucagon receptor agonist for metabolic research. 10 mg and 20 mg vials with an independent Certificate of Analysis for each batch.

CAS number: 2381089-83-2
Sequence: Y-Aib-QGTFTSDYSI-αMeL-LDK-K(γE-AEEA-C20 diacid)-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂
Molecular weight: 4731.33 g/mol
Storage conditions: Lyophilized powder; store at −20 °C, protected from light and moisture.

Volume pricing
Quantity	Price per vial
1–9 vials	€120,00
10+ vials	Request a quote

For Research Use Only — Not for human consumption

Material information.

Retatrutide (LY3437943) is a synthetic peptide that acts, as a single molecule, as an agonist at three receptors: GIP, GLP-1 and glucagon. Its 39-residue sequence includes non-standard amino acids and a C20 fatty diacid side chain that extends its half-life in experimental systems.

In published preclinical and clinical research, retatrutide is studied in the context of metabolic regulation: glucose homeostasis, insulin sensitivity, energy expenditure and body-weight regulation. It is an investigational compound and is not approved for medical use.

Supplied as a lyophilized powder in sealed 10 mg and 20 mg vials, with an independent Certificate of Analysis for each batch. For laboratory research use only.

Pack size refers to the nominal material mass. Product photography is illustrative and does not establish composition or specification.